Table 2.
Urine parameters before and after at least 12 months of treatment
| Group A (n = 65)a |
Group B (n = 10)a |
Group C (n = 22) |
||||
|---|---|---|---|---|---|---|
| Before | After | Before | After | Before | After | |
| Volume (ml/24 h) | 2150 ± 231 | 2319 ± 401b | 1950 ± 279 | 2245 ± 251c | 1650 ± 130 | 1930 ± 210d |
| Calcium (mg/24 h) | 378 (338, 406) | 178 (128, 235)d | 325 (310, 396) | 331 (312, 401) | 156 (93, 233) | 178 (110, 242) |
| Potassium (mEq/24 h) | 63 ± 24 | 89 ± 28d | 66 ± 28 | 75 ± 21 | 61 ± 27 | 74 ± 20 |
| Sodium (mEq/24 h) | 212 ± 49 | 177 ± 65b | 207 ± 53 | 165 ± 71 | 190 ± 71 | 165 ± 47 |
| pH | 6.44 ± 0.33 | 6.91 ± 0.52d | 6.23 ± 0.39 | 6.31 ± 0.30 | 5.64 ± 0.63 | 5.76 ± 0.35 |
| Citrate (mg/24 h) | 268 (196, 282) | 460 (357, 606)d | 247 (184, 278) | 251 (171, 270) | 433 (330, 658) | 480 (345, 590) |
| Oxalate (mg/24 h) | 41 ± 23 | 35 ± 12 | 39 ± 26 | 38 ± 23 | 25 ± 6 | 29 ± 11 |
| Urate (mg/24 h) | 562 ± 181 | 524 ± 91 | 514 ± 161 | 520 ± 79 | 447 ± 87 | 490 ± 61 |
Group A, MSK with SRF on citrate; Group B, MSK with SRF not on citrate; Group C, MSK without SRF not on citrate. Data presented as mean ± SD except calcium and citrate presented as median (Q1, Q3).
a
The data of this group have been previously reported in part (7).
Statistical significance compared with the baseline is shown (
b
P <0.01;
c
P <0.05; and
d
P < 0.001).